ATP-citrate lyase

ATP-citrate lyase Products

  • All (5)
  • ATP-citrate lyase Inhibitors (5)
  • New ATP-citrate lyase Products
Catalog No. Product Name Information Product Use Citations Product Validations
S0277 BMS303141 BMS-303141 is a potent, cell-permeable inhibitor of ATP-citrate lyase (ACL) with IC50 of 0.13 μM. BMS-303141 shows inhibition of total lipid syntheses with IC50 of 8 μM in HepG2 cells.
Cell Death Dis, 2023, 14(7):401
Cancer Commun (Lond), 2022, 42(8):716-749
Cancer Commun (Lond), 2022, 10.1002/cac2.12332
S8878 NDI-091143 NDI-091143 is a potent inhibitor of human ATP-citrate lyase(ACLY) with a Ki of 7.0 nM and an IC50 of 2.1 nM in the ADP-Glo assay.
Cancer Commun (Lond), 2022, 42(8):716-749
Cancer Commun (Lond), 2022, 10.1002/cac2.12332
Endocrine, 2022, 10.1007/s12020-022-03124-6
S7953 Bempedoic acid (ETC-1002) Bempedoic acid (ETC-1002),also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies.ETC-1002 is an activator of hepatic AMP-activated protein kinase (AMPK). It has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
iScience, 2023, 26(12):108532
Oncol Rep, 2023, 49(2)32
Biomed Pharmacother, 2021, 144:112325
E1287New SB 204990 SB-204990, a γ-lactone prodrug of SB-201076, is a potent and specific inhibitor of ATP citrate lyase (ACLY). SB 204990 potently limits SARS-CoV-2 replication in vivo.
S4864 2-Furoic acid 2-Furoic acid (2-Furancarboxylic acid, Pyromucic acid, 2-Carboxyfuran, α-furancarboxylic acid, α-furoic acid) is an organic compound most widely found in food products as a preservative and a flavoring agent.
S0277 BMS303141 BMS-303141 is a potent, cell-permeable inhibitor of ATP-citrate lyase (ACL) with IC50 of 0.13 μM. BMS-303141 shows inhibition of total lipid syntheses with IC50 of 8 μM in HepG2 cells.
Cell Death Dis, 2023, 14(7):401
Cancer Commun (Lond), 2022, 42(8):716-749
Cancer Commun (Lond), 2022, 10.1002/cac2.12332
S8878 NDI-091143 NDI-091143 is a potent inhibitor of human ATP-citrate lyase(ACLY) with a Ki of 7.0 nM and an IC50 of 2.1 nM in the ADP-Glo assay.
Cancer Commun (Lond), 2022, 42(8):716-749
Cancer Commun (Lond), 2022, 10.1002/cac2.12332
Endocrine, 2022, 10.1007/s12020-022-03124-6
S7953 Bempedoic acid (ETC-1002) Bempedoic acid (ETC-1002),also known as Bempedoic acid, is an orally available, once-daily LDL-C lowering small molecule designed to lower elevated levels of LDL-C and to avoid side effects associated with existing LDL-C lowering therapies.ETC-1002 is an activator of hepatic AMP-activated protein kinase (AMPK). It has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
iScience, 2023, 26(12):108532
Oncol Rep, 2023, 49(2)32
Biomed Pharmacother, 2021, 144:112325
E1287New SB 204990 SB-204990, a γ-lactone prodrug of SB-201076, is a potent and specific inhibitor of ATP citrate lyase (ACLY). SB 204990 potently limits SARS-CoV-2 replication in vivo.
S4864 2-Furoic acid 2-Furoic acid (2-Furancarboxylic acid, Pyromucic acid, 2-Carboxyfuran, α-furancarboxylic acid, α-furoic acid) is an organic compound most widely found in food products as a preservative and a flavoring agent.
E1287New SB 204990 SB-204990, a γ-lactone prodrug of SB-201076, is a potent and specific inhibitor of ATP citrate lyase (ACLY). SB 204990 potently limits SARS-CoV-2 replication in vivo.

Choose Selective ATP-citrate lyase Inhibitors

Tags: ATP-citrate lyase inhibitor